Concurrently, protein expression levels of VCAM-1, ICAM-1, resistin, biomarkers in plasmas are clearly up regulated during initial stage of cancer, but significantly down regulated in later stages of cancer in patients. The gene discussed is ICAM1; the disease is cancer.